Skip to main content

Advertisement

Log in

Genetics of Hereditary Angioedema Revisited

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Contemporary genetic research has provided evidences that angioedema represents a diverse family of disorders related to kinin metabolism, with a much greater genetic complexity than was initially considered. Convincing data have also recently been published indicating that the clinical heterogeneity of hereditary angioedema due to C1 inhibitor deficiency (classified as C1-INH-HAE) could be attributed at least in part, either to the type of SERPING1 mutations or to mutations in genes encoding for enzymes involved in the metabolism and function of bradykinin. Alterations detected in at least one more gene (F12) are nowadays considered responsible for 25 % of cases of hereditary angioedema with normal C1-INH (type III hereditary angioedema (HAE), nlC1-INH-HAE). Interesting data derived from genetic approaches of non-hereditary angioedemas indicate that other immune pathways might be implicated in the pathogenesis of HAE. More than 125 years after the recognition of the hereditary nature of HAE by Osler, the heterogeneity of clinical expressions, the genetics of this disorder, and the genotype-phenotype relationships, still presents a challenge that will be discussed in this review. Large scale, in-depth genetic studies are expected not only to answer these emerging questions but also to further elucidate many of the unmet aspects of angioedema pathogenesis. Uncovering genetic biomarkers affecting the severity of the disease and/or the effectiveness of the various treatment modalities might lead to the prevention of attacks and the optimization of C1-INH-HAE management that is expected to provide a valuable benefit to the sufferers of angioedema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cicardi M, Igarashi T, Kim MS, Frangi D, Agostoni A, Davis AE 3rd (1987) Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema. J Clin Invest 80:1640–1643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Stoppa-Lyonnet D, Tosi M, Laurent J, Sobel A, Lagrue G, Meo T (1987) Altered C1 inhibitor genes in type I hereditary angioedema. N Engl J Med 317:1–6

    Article  CAS  PubMed  Google Scholar 

  3. Dewald G, Bork K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343:1286–1289

    Article  CAS  PubMed  Google Scholar 

  4. Speletas M, Szilagyi A, Psarros F, Moldovan D, Magerl M, Kompoti M et al (2015) Hereditary angioedema: molecular and clinical differences among European populations. J Allergy Clin Immunol 135:570–573

    Article  PubMed  Google Scholar 

  5. Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M (2008) Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol 45:3536–3544

    Article  CAS  PubMed  Google Scholar 

  6. Csuka D, Szilágyi Á, Farkas H (2015) Hereditary angioedema due to C1-inhibitor deficiency—from a genetic point of view. Hered Genet 4:e112

    Google Scholar 

  7. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A et al (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 33(Suppl 1):145–156

    Article  CAS  Google Scholar 

  8. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, HAWK Under the Patronage of EAACI et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602–616

    Article  CAS  PubMed  Google Scholar 

  9. Bors A, Csuka D, Varga L, Farkas H, Tordai A, Füst G, Szilagyi A (2013) Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations. J Allergy Clin Immunol 131:1708–1711

    Article  CAS  PubMed  Google Scholar 

  10. Speletas M, Szilagyi A, Csuka D, Koutsostathis N, Psarros F, Moldovan D et al (2015) F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Allergy 70:1661–1664

    Article  CAS  PubMed  Google Scholar 

  11. Davis AE 3rd, Whitehead AS, Harrison RA, Dauphinais A, Bruns GA, Cicardi M, Rosen FS (1986) Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11. Proc Natl Acad Sci U S A 83:3161–3165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bock SC, Skriver K, Nielsen E, Thogersen HC, Wiman B, Donaldson VH, Eddy RL, Marrinan J, Radziejewska E, Huber R et al (1986) Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry 25:4292–4301

    Article  CAS  PubMed  Google Scholar 

  13. Beinrohr L, Harmat V, Dobó J, Lörincz Z, Gál P, Závodszky P (2007) C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. J Biol Chem 282:21100–21109

    Article  CAS  PubMed  Google Scholar 

  14. Russell JA, Whaley K, Heaphy S (1997) The sequence of a cDNA encoding functional murine C1-inhibitor protein. Biochim Biophys Acta 1352:156–160

    Article  CAS  PubMed  Google Scholar 

  15. Lener M, Vinci G, Duponchel C, Meo T, Tosi M (1998) Molecular cloning, gene structure and expression profile of mouse C1 inhibitor. Eur J Biochem 254:117–122

    Article  CAS  PubMed  Google Scholar 

  16. Carugati A, Pappalardo E, Zingale LC, Cicardi M (2001) C1-inhibitor deficiency and angioedema. Mol Immunol 38:161–173

    Article  CAS  PubMed  Google Scholar 

  17. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1–9

    Article  CAS  PubMed  Google Scholar 

  18. Kalmár L, Hegedüs T, Farkas H, Nagy M, Tordai A (2005) HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat 25:1–5

    Article  PubMed  CAS  Google Scholar 

  19. Amrani N, Sachs MS, Jacobsen A (2006) Early nonsense: mRNA decay solves a translational problem. Nat Rev Mol Cell Biol 7:415–425

    Article  CAS  PubMed  Google Scholar 

  20. Carter PE, Duponchel C, Tosi M, Fothergill JE (1991) Complete nucleotide sequence for the C1 inhibitor with an unusually high density of Alu elements. Eur J Biochem 197:301–308

    Article  CAS  PubMed  Google Scholar 

  21. Antonarakis SE, The Nomenclature Working Group (1998) Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1–3

    Article  CAS  PubMed  Google Scholar 

  22. Parad RB, Kramer J, Strunk RC, Rosen FS, Davis AE (1990) Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. Proc Natl Acad Sci U S A 87:6786–6790

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Longhurst H, Cicardi M (2012) Hereditary angio-oedema. Lancet 379:474–481

    Article  PubMed  Google Scholar 

  24. Blanch A, Roche O, Urrutia I, Gamboa P, Fontán G, López-Trascasa M (2006) First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118:1330–1335

    Article  PubMed  Google Scholar 

  25. Lopez-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, López-Trascasa M (2010) A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol 126:1307–1310

    Article  CAS  PubMed  Google Scholar 

  26. Bafunno V, Divella C, Sessa F, Tiscia GL, Castellano G, Gesualdo L, Margaglione M, Montinaro V (2013) De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J Allergy Clin Immunol 132:748–750

    Article  CAS  PubMed  Google Scholar 

  27. Yu TC, Shyur SD, Huang LH, Wen DC, Li JS (2007) Paternal mosaicism and hereditary angioedema in a Taiwanese family. Ann Allergy Asthma Immunol 99:375–379

    Article  CAS  PubMed  Google Scholar 

  28. Guarino S, Perricone C, Guarino MD, Giardina E, Gambardella S, Rosaria D’Apice M, Bulli C, Perricone R, Novelli G (2006) Gonadal mosaicism in hereditary angioedema. Clin Genet 70:83–85

    Article  CAS  PubMed  Google Scholar 

  29. Cicardi M, Igarashi T, Rosen FS, Davis AE 3rd (1987) Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema. J Clin Invest 79:698–702

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS (1983) Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 71:1041–1046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kramer J, Rosen FS, Colten HR, Rajczy K, Strunk RC (1993) Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema. J Clin Invest 91:1258–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ernst SC, Circolo A, Davis AE 3rd, Gheesling-Mullis K, Fliesler M, Strunk RC (1996) Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8. J Immunol 157:405–410

    CAS  PubMed  Google Scholar 

  33. Pappalardo E, Zingale LC, Cicardi M (2004) C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol 114:638–644

    Article  CAS  PubMed  Google Scholar 

  34. Emonts M, de Jongh CE, Houwing-Duistermaat JJ, van Leeuwen WB, de Groot R, Verbrugh HA, Hermans PW, van Belkum A (2007) Association between nasal carriage of Staphylococcus aureus and the human complement cascade activator serine protease C1 inhibitor (C1INH) valine vs. methionine polymorphism at amino acid position 480. FEMS Immunol Med Microbiol 50:330–332

    Article  CAS  PubMed  Google Scholar 

  35. Ennis S, Jomary C, Mullins R, Cree A, Chen X, Macleod A, Jones S, Collins A, Stone E, Lotery A (2008) Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study. Lancet 372:1828–1834

    Article  CAS  PubMed  Google Scholar 

  36. Kralovicova J, Vorechovsky I (2009) SERPING1 rs2511988 and age-related macular degeneration. Lancet 373:461–462

    Article  PubMed  Google Scholar 

  37. Lu F, Zhao P, Fan Y, Tang S, Hu J, Liu X et al (2010) An association study of SERPING1 gene and age-related macular degeneration in a Han Chinese population. Mol Vis 16:1–6

    PubMed  PubMed Central  Google Scholar 

  38. Nakata I, Yamashiro K, Yamada R, Gotoh N, Nakanishi H, Hayashi H et al (2011) Association between the SERPING1 gene and age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese. PLoS One 6:e19108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Zahedi R, Wisnieski J, Davies AE 3rd (1997) Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol 159:983–988

    CAS  PubMed  Google Scholar 

  40. Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, Tosi M (2000) Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 106:1147–1154

    Article  CAS  PubMed  Google Scholar 

  41. Pappalardo E, Zingale LC, Terlizzi A, Zanichelli A, Folcioni A, Cicardi M (2002) Mechanisms of C1-inhibitor deficiency. Immunobiology 205:542–551

    Article  CAS  PubMed  Google Scholar 

  42. Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B (2005) C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol 27:286–298

    Article  CAS  PubMed  Google Scholar 

  43. Tosi M, Duponchel C, Bourgarel P, Colomb M, Meo T (1986) Molecular cloning of human C1 inhibitor: sequence homologies with α1-antitrypsin and other members of the serpins superfamily. Gene 42:265–272

    Article  CAS  PubMed  Google Scholar 

  44. Stoppa-Lyonnet D, Carter PE, Meo T, Tosi M (1990) Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements. Proc Natl Acad Sci U S A 87:1551–1555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Skriver K, Radziejewska E, Silbermann JA, Donaldson VH, Bock SC (1989) CpG mutations in the reactive site of human C1 inhibitor. J Biol Chem 264:3066–3071

    CAS  PubMed  Google Scholar 

  46. Roche O, Blanch A, Duponchel C, Fontan G, Tosi M, Lopez-Trascasa M (2005) Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort. Hum Mutat 26:135–44

    Article  CAS  PubMed  Google Scholar 

  47. Speletas M, Boukas K, Papadopoulou-Alataki E, Tsitsami E, Germenis AE (2009) Hereditary angioedema in Greek families caused by novel and recurrent mutations. Hum Immunol 70:925–929

    Article  CAS  PubMed  Google Scholar 

  48. Davies MJ, Lomas DA (2008) The molecular aetiology of the serpinopathies. Int J Biochem Cell Biol 40:1273–1286

    Article  CAS  PubMed  Google Scholar 

  49. Eldering E, Verpy E, Roem D, Meo T, Tosi M (1995) COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J Biol Chem 270:2579–2587

    Article  CAS  PubMed  Google Scholar 

  50. Aulak KS, Eldering E, Hack CE, Lubbers YP, Harrison RA, Mast A, Cicardi M, Davis AE 3rd (1993) A hinge region mutation in C1-inhibitor (Ala436→Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem 268:18088–18094

    CAS  PubMed  Google Scholar 

  51. Madsen DE, Hansen S, Gram J, Bygum A, Drouet C, Sidelmann JJ (2014) Presence of C1-inhibitor polymers in a subset of patients suffering from hereditary angioedema. PLoS One 9:e112051

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Maas C, Govers-Riemslag JW, Bouma B, Schiks B, Hazenberg BP, Lokhorst HM et al (2008) Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 118:3208–3218

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M (2009) C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 15:69–78

    Article  CAS  PubMed  Google Scholar 

  54. Ghannam A, Sellier P, Defendi F, Favier B, Charignon D, López-Lera A, López-Trascasa M, Ponard D, Drouet C (2015) C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay. Allergy 70:1103–1111

    Article  CAS  PubMed  Google Scholar 

  55. Duponchel C, Djenouhat K, Frémeaux-Bacchi V, Monnier N, Drouet C, Tosi M (2006) Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH. Hum Mutat 27:295–296

    Article  PubMed  Google Scholar 

  56. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, López-Trascasa M (2005) Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 94:498–503

    Article  PubMed  Google Scholar 

  57. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantifications of 40 nucleic acid sequences by multiplex ligation dependent probe amplification. Nucleic Acids Res 30:e57

    Article  PubMed  PubMed Central  Google Scholar 

  58. Kang HR, Yim EY, Oh SY, Chang YS, Kim YK, Cho SH, Min KU, Kim YY (2006) Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations. Allergy 61:260–264

    Article  CAS  PubMed  Google Scholar 

  59. Colobran R, Pujol-Borrell R, Hernández-González M, Guilarte M (2014) A novel splice site mutation in the SERPING1 gene leads to haploinsufficiency by complete degradation of the mutant allele mRNA in a case of familial hereditary angioedema. J Clin Immunol 34:521–523

    Article  PubMed  Google Scholar 

  60. Bork K, Davis-Lorton M (2013) Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management. Eur Ann Allergy Clin Immunol 45:7–16

    CAS  PubMed  Google Scholar 

  61. Zuraw BL (2008) Hereditary angioedema. N Engl J Med 359:1027–1036

    Article  CAS  PubMed  Google Scholar 

  62. Davis AE 3rd (2008) Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol 100:S7–S12

    Article  CAS  PubMed  Google Scholar 

  63. Cardarelli W (2013) Managed care implications of hereditary angioedema. Am J Manag Care 19(7 Suppl):s119–24

    PubMed  Google Scholar 

  64. Kramer J, Rosen FS, Colten HR, Kramer J, Rosen FS, Colten HR (1993) Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema. J Clin Invest 91:1258–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M (1996) Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genet 59:308–319

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114(3 Suppl):S51–S131

    Article  PubMed  Google Scholar 

  67. Xu YY, Zhi YX, Yin J, Wang LL, Wen LP, Gu JQ, Guan K, Craig T, Zhang HY (2012) Mutational spectrum and geno-phenotype correlation in Chinese families with hereditary angioedema. Allergy 67:1430–1436

    Article  CAS  PubMed  Google Scholar 

  68. Bafunno V, Bova M, Loffredo S, Divella C, Petraroli A, Marone G, Montinaro V, Margaglione M, Triggiani M (2014) Mutational spectrum of the C1 inhibitor gene in a cohort of Italian patients with hereditary angioedema: description of nine novel mutations. Ann Hum Genet 78:73–82

    Article  CAS  PubMed  Google Scholar 

  69. Farkas H (2010) Pediatric hereditary angioedema due to C1-inhibitor deficiency. Allergy, Asthma Clin Immunol 6:18

    Article  Google Scholar 

  70. Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119:267–274

    Article  PubMed  Google Scholar 

  71. Andrejević S, Korošec P, Šilar M, Košnik M, Mijanović R, Bonači-Nikolić B, Rijavec M (2015) Hereditary angioedema due to C1 inhibitor deficiency 1 in Serbia: two novel mutations and evidence of genotype-phenotype correlation. PLoS One 10(11): e0142174

  72. Kalmár L, Bors A, Farkas H, Vas S, Fandl B, Varga L, Füst G, Tordai A (2003) Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema. Hum Mutat 22:498

    Article  PubMed  CAS  Google Scholar 

  73. Martinho A, Mendes J, Simões O, Nunes R, Gomes J, Dias Castro E et al (2013) Mutations analysis of C1 inhibitor coding sequence gene among Portuguese patients with hereditary angioedema. Mol Immunol 53:431–434

    Article  CAS  PubMed  Google Scholar 

  74. Cumming SA, Halsall DJ, Ewan PW, Lomas DA (2003) The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angiooedema. J Med Genet 40:e114

    Article  PubMed  PubMed Central  Google Scholar 

  75. Bygum A, Fagerberg CR, Ponard D, Monnier N, Lunardi J, Drouet C (2011) Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency. Allergy 66:76–84

    Article  CAS  PubMed  Google Scholar 

  76. Blaskó B, Széplaki G, Varga L, Ronai Z, Prohászka Z, Sasvari-Szekely M, Visy B, Farkas H, Füst G (2007) Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE). Mol Immunol 44:2667–2674

    Article  PubMed  CAS  Google Scholar 

  77. Lung CC, Chan EK, Zuraw BL (1997) Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency. J Allergy Clin Immunol 99:134–146

    CAS  PubMed  Google Scholar 

  78. Freiberger T, Vyskocilová M, Kolárová L, Kuklínek P, Krystůfková O, Lahodná M, Hanzlíková J, Litzman J (2002) Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema. Hum Immunol 63:492–494

    Article  CAS  PubMed  Google Scholar 

  79. Freiberger T, Grombiříková H, Ravčuková B, Jarkovský J, Kuklínek P, Kryštůfková O, Hanzlíková J et al (2011) No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Scand J Immunol 74:100–106

    Article  CAS  PubMed  Google Scholar 

  80. Kaplan AP, Joseph K (2014) Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol 121:41–89

    Article  CAS  PubMed  Google Scholar 

  81. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y (1998) A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 91:2010–2014

    CAS  PubMed  Google Scholar 

  82. Bork K, Barnstedt S, Koch P, Traupe H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356:213–217

    Article  CAS  PubMed  Google Scholar 

  83. Binkley K, Davis AE III (2000) Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106:546–550

    Article  CAS  PubMed  Google Scholar 

  84. Riedl MA (2013) Hereditary angioedema with normal C1-INH (HAE type III). J Allergy Clin Immunol Pract 1:427–432

    Article  PubMed  Google Scholar 

  85. Royle NJ, Nigli M, Cool D, MacGillivray RT, Hamerton JL (1988) Structural gene encoding human factor XII is located at 5q33-qter. Somat Cell Mol Genet 14:217–221

    Article  CAS  PubMed  Google Scholar 

  86. Schloesser M, Zeerleder S, Lutze G, Halbmayer WM, Hofferbert S, Hinney B et al (1997) Mutations in the human factor XII gene. Blood 90:3967–3977

    CAS  PubMed  Google Scholar 

  87. Bork K, Wulff K, Meinke P, Wagner N, Hardt J, Witzke G (2011) A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol 141:31–35

    Article  CAS  PubMed  Google Scholar 

  88. Bork K, Wulff K, Hardt J, Witzke G, Lohse P (2014) Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor. Haemophilia 20:e372–e375

    Article  CAS  PubMed  Google Scholar 

  89. Kiss N, Barabas E, Varnai K, Halász A, Varga LÁ, Prohászka Z, Farkas H, Szilágyi Á (2013) Novel duplication in the F12 gene in a patient with recurrent angioedema. Clin Immunol 149:142–145

    Article  CAS  PubMed  Google Scholar 

  90. Moreno AS, Valle SO, Levy S, França AT, Serpa FS, Arcuri HA, Palma MS et al (2015) Coagulation factor XII gene mutation in Brazilian families with hereditary angioedema with normal C1 inhibitor. Int Arch Allergy Immunol 166:114–120

    Article  CAS  PubMed  Google Scholar 

  91. Cichon S, Martin L, Hennies HC, Müller F, Van Driessche K, Karpushova A, Stevens W et al (2006) Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79:1098–1104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Bork K, Kleist R, Hardt J, Witzke G (2009) Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys. Blood Coagul Fibrinolysis 20:325–332

    Article  CAS  PubMed  Google Scholar 

  93. Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C, Monnier N, Lunardi J, Massot C, Gompel A (2009) Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. Ann Allergy Asthma Immunol 103:448

    Article  PubMed  Google Scholar 

  94. Bork K, Wulff K, Witzke G, Stanger C, Lohse P, Hardt J (2013) Antihistamine-resistant angioedema in women with negative family history: estrogens and F12 gene mutations. Am J Med 126:1142.e9–1142.e14

    Article  CAS  Google Scholar 

  95. Gelincik A, Demir S, Olgaç M, Karaman V, Toksoy G, Çolakoğlu B, Büyüköztürk S, Uyguner ZO (2015) Idiopathic angioedema with F12 mutation: is it a new entity? Ann Allergy Asthma Immunol 114:154–156

    Article  PubMed  Google Scholar 

  96. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P (2010) Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 40:50–61

    CAS  PubMed  Google Scholar 

  97. Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D et al (2005) A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 77:617–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Woodard-Grice AV, Lucisano AC, Byrd JB, Stone ER, Simmons WH, Brown NJ (2010) Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics 20:532–536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Cilia La Corte AL, Carter AM, Rice GI, Duan QL, Rouleau GA, Adam A, Grant PJ, Hooper NM (2011) A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema. Hum Mutat 32:1326–13231

    Article  CAS  PubMed  Google Scholar 

  100. Moholisa RR, Rayner BR, Patricia Owen E, Schwager SL, Stark JS, Badri M, Cupido CL, Sturrock ED (2013) Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans. J Clin Hypertens 15:413–419

    Article  CAS  Google Scholar 

  101. Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ (2008) Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension 51:454–459

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  102. Pare G, Kubo M, Byrd JB, McCarty CA, Woodard-Grice A, Teo KK, Anand SS et al (2013) Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics 23:470–478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A (1993) Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87–146

    CAS  PubMed  Google Scholar 

  104. Salek-Ardakani S, So T, Halteman BS, Altman A, Croft M (2004) Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J Immunol 173:6440–6447

    Article  CAS  PubMed  Google Scholar 

  105. Bohlander SK (2005) ETV6: a versatile player in leukemogenesis. Semin Cancer Biol 15:162–174

    Article  CAS  PubMed  Google Scholar 

  106. Boily G, Larose J, Langlois S, Sinnett D (2007) Identification of transcripts modulated by ETV6 expression. Br J Haematol 136:48–62

    Article  CAS  PubMed  Google Scholar 

  107. Sakurai T, Yamada T, Kihara-Negishi F, Teramoto S, Sato Y, Izawa T, Oikawa T (2003) Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. Int J Oncol 22:1327–1333

    CAS  PubMed  Google Scholar 

  108. Bocsi J, Richter M, Hambsch J, Barten MJ, Dahnert I, Schneider P, Tárnok A (2006) Transient Th1/Th2 disbalance indicates postoperative effusions and edema after cardiopulmonary bypass in children. Cytometry A 69:165–168

    Article  PubMed  CAS  Google Scholar 

  109. Triggianese P, Chimenti MS, Toubi E, Ballanti E, Guarino MD, Perricone C, Perricone R (2015) The autoimmune side of hereditary angioedema: insights on the pathogenesis. Autoimmun Rev 14:665–669

    Article  CAS  PubMed  Google Scholar 

  110. Triggianese P, Guarino MD, Ballanti E, Chimenti MS, Perricone R (2014) Hereditary angioedema and autoimmunity. Isr Med Assoc J 16:622–624

    PubMed  Google Scholar 

  111. Salemi M, Mandalà V, Muggeo V, Misiano G, Milano S, Colonna-Romano G, Arcoleo F, Cillari E (2015) Growth factors and IL-17 in hereditary angioedema. Clin Exp Med

  112. Matthews KW, Mueller-Ortiz SL, Wetsel RA (2004) Carboxypeptidase N: a pleiotropic regulator of inflammation. Mol Immunol 40:785–793

    Article  CAS  PubMed  Google Scholar 

  113. Mathews KP, Pan PM, Gardner NJ, Hugli TE (1980) Familial carboxypeptidase N deficiency. Ann Intern Med 93:443–445

    Article  CAS  PubMed  Google Scholar 

  114. Mathews KP, Curd JG, Hugli TE (1986) Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency. J Clin Immunol 6:87–91

    Article  CAS  PubMed  Google Scholar 

  115. Mathews KP (1986) Deficiencies in regulator proteins 4. Anaphylatoxin inactivator. Prog Allergy 39:344–351

    CAS  PubMed  Google Scholar 

  116. Cao H, Hegele RA (2003) DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency. J Hum Genet 48:20–22

    Article  CAS  PubMed  Google Scholar 

  117. Willemse JL, Chen D, Hendriks DF (2008) Major carboxypeptidase N deficiency. Clin Chim Acta 389:181–182

    Article  CAS  PubMed  Google Scholar 

  118. Dessart P, Defendi F, Humeau H, Nicolie B, Sarre ME, Charignon D, Ponard D, Cichon S, Drouet C, Martin L (2015) Distinct conditions support a novel classification for bradykinin-mediated angio-oedema. Dermatology 230:324–331

    Article  CAS  PubMed  Google Scholar 

  119. Reardon S (2015) Precision-medicine plan raises hopes. Nature 517:540

    Article  CAS  PubMed  Google Scholar 

  120. Tannenbaum H (1982) Angioedema provoked by olfactory stimuli. Can Med Assoc J 127:735–736

    CAS  PubMed  PubMed Central  Google Scholar 

  121. Perricone C, Agmon-Levin N, Shoenfeld N, de Carolis C, Guarino MD et al (2011) Evidence of impaired sense of smell in hereditary angioedema. Allergy 66:149–154

    Article  CAS  PubMed  Google Scholar 

  122. Buettner JA, Glusman G, Ben-Arie N, Ramos P, Lancet D, Evans GA (1998) Organization and evolution of olfactory receptor genes on human chromosome 11. Genomics 53:56–68

    Article  CAS  PubMed  Google Scholar 

  123. O’Lone R, Frith MC, Karlsson EK, Hansen U (2004) Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18:1859–1875

    Article  PubMed  CAS  Google Scholar 

  124. Farsetti A, Misiti S, Citarella F, Farsetti A, Pontecorvi A, Fantoni A (1995) Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 136:5076–5083

    CAS  PubMed  Google Scholar 

  125. Bourdeau V, Deschênes J, Metivier R, Nagai Y, Nguyen D, Hudson T, White J, Gannon F, Mader S (2004) Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol 18:1411–1427

    Article  CAS  PubMed  Google Scholar 

  126. Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I (2014) Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. Int Arch Allergy Immunol 165:119–127

    Article  CAS  PubMed  Google Scholar 

  127. Weiler CR, van Dellen RG (2006) Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc 81:958–972

    Article  CAS  PubMed  Google Scholar 

  128. Caballero T (2013) Angio-oedema due to hereditary C1 inhibitor deficiency in children. Allergol Immunopathol (Madr) 41:45–53

    Article  CAS  Google Scholar 

  129. Nielsen EW, Johansen HT, Holt J, Mollnes TE (1994) C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res 35:184–187

    Article  CAS  PubMed  Google Scholar 

  130. Roach B, Kim Y, Jerome E, Michael AF (1981) Influence of age and sex on serum complement components in children. Am J Dis Child 135:918–920

    CAS  PubMed  Google Scholar 

  131. Bautista-Llácer R, Alberola TM, Vendrell X, Fernández E, Pérez-Alonso M (2010) Case report: first successful application of preimplantation genetic diagnosis for hereditary angiooedema. Reprod Biomed Online 21:658–662

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anastasios E. Germenis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Germenis, A.E., Speletas, M. Genetics of Hereditary Angioedema Revisited. Clinic Rev Allerg Immunol 51, 170–182 (2016). https://doi.org/10.1007/s12016-016-8543-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-016-8543-x

Keywords

Navigation